KRAS and intervertebral disk degenerative disorder: Thus, the four identified hub genes involved in the MAPK signaling pathway (i.e., KRAS, JUN, RAP1B, and TNF) may demonstrate clinical utility in the diagnosis and subtyping of IDD, ultimately leading to improved prevention and treatment strategies.